Trial Profile
A phase I study of reactogenicity, safety, immunogenicity, and pock lesion formation (take rate) of a cell-cultured smallpox vaccine (CCSV) compared to a calf lymph vaccine (Dryvax)
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Oct 2018
Price :
$35
*
At a glance
- Drugs Smallpox vaccine (Primary) ; ACAM 2000
- Indications Smallpox
- Focus Adverse reactions
- 06 Nov 2005 New trial record.